Ardent Health Partners, LLC (ARDT)
Automate Your Wheel Strategy on ARDT
With Tiblio's Option Bot, you can configure your own wheel strategy including ARDT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ARDT
- Rev/Share 44.9995
- Book/Share 11.6088
- PB 0.965
- Debt/Equity 1.8378
- CurrentRatio 2.0754
- ROIC 0.1545
- MktCap 1217095289.0
- FreeCF/Share 1.1019
- PFCF 7.8579
- PE 5.8268
- Debt/Assets 0.4415
- DivYield 0
- ROE 0.1709
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 3
- DCF Score 1
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ARDT | KeyBanc Capital Markets | Overweight | Sector Weight | -- | -- | Nov. 17, 2025 |
| Downgrade | ARDT | Morgan Stanley | Overweight | Equal Weight | -- | -- | Nov. 14, 2025 |
| Initiation | ARDT | Goldman | -- | Neutral | -- | $19 | Oct. 14, 2025 |
| Initiation | ARDT | UBS | -- | Buy | -- | $17 | Sept. 10, 2025 |
| Downgrade | ARDT | BofA Securities | Neutral | Underperform | -- | $14.6 | July 16, 2025 |
| Resumed | ARDT | JP Morgan | -- | Neutral | -- | $20 | Dec. 17, 2024 |
| Initiation | ARDT | KeyBanc Capital Markets | -- | Overweight | -- | $24 | Oct. 11, 2024 |
News
ARDT LAWSUIT ALERT: Levi & Korsinsky Notifies Ardent Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Published: February 04, 2026 by: PRNewsWire
Sentiment: Neutral
NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025.
Read More
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health
Published: February 04, 2026 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their Options
Read More
Deadline Alert: Ardent Health, Inc. (ARDT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Published: February 04, 2026 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”).
Read More
ARDT ALERT: Hagens Berman Scrutinizing Suit Against Ardent Health (ARDT) Over Alleged Revenue Cycle Deception and $97M Adjustments
Published: February 04, 2026 by: PRNewsWire
Sentiment: Neutral
ARDT Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Feb. 4, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing an updated notice to investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top executives. CLICK HERE TO SUBMIT YOUR ARDT LOSSES Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves.
Read More
INVESTOR ALERT: Ardent Health, Inc. (ARDT) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Published: February 04, 2026 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Feb. 04, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”), have until Monday, March 9, 2026 to seek appointment as lead plaintiff of the Ardent Health class action lawsuit. Captioned Postiwala v.
Read More
Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Published: February 04, 2026 by: GlobeNewsWire
Sentiment: Neutral
New class action for Ardent Health (ARDT) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 3/9/2026.
Read More
Ardent Health, Inc. (ARDT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: February 03, 2026 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES, Feb. 3, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT) have opportunity to lead the securities fraud class action lawsuit.
Read More
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDT
Published: February 03, 2026 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - February 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period"), of the important March 9, 2026 lead plaintiff deadline. SO WHAT: If you purchased Ardent Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardent Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDT
Published: February 03, 2026 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: February 03, 2026 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before March 9, 2026.
Read More
Hagens Berman Scrutinizing Suit Against Ardent Health (ARDT) Over Alleged Revenue Cycle Deception and $97M Adjustments
Published: February 03, 2026 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing an updated notice to investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top executives. CLICK HERE TO SUBMIT YOUR ARDT LOSSES Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves.
Read More
ARDENT HEALTH STOCK NOTICE: Ardent Health, Inc. (ARDT) Accused of Misleading Investors in BFA Law's Securities Fraud Class Action – Court Deadline is March 9
Published: February 03, 2026 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE:ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-lawsuit.
Read More
ARDT ALERT: Hagens Berman Scrutinizing Suit Against Ardent Health (ARDT) Over Alleged Revenue Cycle Deception and $97M Adjustments
Published: February 02, 2026 by: PRNewsWire
Sentiment: Neutral
ARDT Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, Feb. 2, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing an updated notice to investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top executives. CLICK HERE TO SUBMIT YOUR ARDT LOSSES Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves.
Read More
Shareholder Rights Law Firm Robbins LLP Urges ARDT Investors to Contact the Firm About Leading the Class Action Lawsuit Against Ardent Health, Inc.
Published: February 02, 2026 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2025 and November 12, 2025. Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities.
Read More
Bragar Eagel & Squire, P.C. Reminds Ardent Health, Inc. Investors of the March 9th Lead Plaintiff Deadline for the Filed Class Action Lawsuit and Urges Investors to Contact the Firm
Published: February 02, 2026 by: GlobeNewsWire
Sentiment: Neutral
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Ardent Health (ARDT) To Contact Him Directly To Discuss Their Options
Read More
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDT
Published: February 02, 2026 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - February 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period"), of the important March 9, 2026 lead plaintiff deadline. SO WHAT: If you purchased Ardent Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
Shareholders who lost money in shares of Ardent, Inc. (NYSE: ARDT) Should Contact Wolf Haldenstein Immediately
Published: February 02, 2026 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or Ardent, Inc. (NYSE: ARDT) (“Ardent”) that a federal securities class action has been filed on behalf of investors who purchased Ardent between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). Investors have until March 9, 2026 to seek appointments as lead plaintiff.
Read More
Portnoy Law Firm Announces Class Action on Behalf of Ardent Health, Inc.. Investors
Published: February 02, 2026 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Feb. 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ardent Health, Inc., (“Ardent” or the "Company") (NYSE: ARDT) investors off a class action on behalf of investors that bought securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). Ardent investors have until March 9, 2026 to file a lead plaintiff motion.
Read More
Deadline Alert: Ardent Health, Inc. (ARDT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Published: January 30, 2026 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”).
Read More
ARDT ALERT: Hagens Berman Scrutinizing Suit Against Ardent Health (ARDT) Over Alleged Revenue Cycle Deception and $97M Adjustments
Published: January 30, 2026 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing an updated notice to investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top executives. CLICK HERE TO SUBMIT YOUR ARDT LOSSES Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves.
Read More
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health
Published: January 30, 2026 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Jan. 30, 2026 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ardent Health, Inc. ("Ardent" or the "Company") …
Read More
ARDT ALERT: Hagens Berman Scrutinizing Suit Against Ardent Health (ARDT) Over Alleged Revenue Cycle Deception and $97M Adjustments
Published: January 29, 2026 by: PRNewsWire
Sentiment: Neutral
Partner Reed Kathrein Scrutinizing Claims of Detailed Hindsight Analysis Against Revealed Mechanical Write-Offs SAN FRANCISCO, Jan. 29, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing an updated notice to investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top executives. CLICK HERE TO SUBMIT YOUR ARDT LOSSES Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves.
Read More
Portnoy Law Firm Announces Class Action on Behalf of Ardent Health, Inc.. Investors
Published: January 29, 2026 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ardent Health, Inc., (“Ardent” or the "Company") (NYSE: ARDT) investors off a class action on behalf of investors that bought securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). Ardent investors have until March 9, 2026 to file a lead plaintiff motion.
Read More
ARDT SECURITIES: Ardent Health, Inc. Investors that Lost Money on their Securities are Notified to Contact BFA Law about its Ongoing Securities Class Action before March 9
Published: January 28, 2026 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - January 28, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-lawsuit.
Read More
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDT
Published: January 28, 2026 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - January 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period"), of the important March 9, 2026 lead plaintiff deadline. SO WHAT: If you purchased Ardent Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDT
Published: January 28, 2026 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the “Class Period”), of the important March 9, 2026 lead plaintiff deadline.
Read More
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health
Published: January 28, 2026 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their Options
Read More
Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Published: January 28, 2026 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ardent securities between July 18, 2024 and November 12, 2025, both dates inclusive (the “Class Period”).
Read More
ARDT INVESTORS: BFA Law Notifies Ardent Health Investors with Losses of its Pending Securities Fraud Class Action and Upcoming March 9 Legal Deadline
Published: January 27, 2026 by: Newsfile Corp
Sentiment: Neutral
New York, New York--(Newsfile Corp. - January 27, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-lawsuit.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardent Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDT
Published: January 27, 2026 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
About Ardent Health Partners, LLC (ARDT)
- IPO Date
- Website https://www.ardenthealth.com
- Industry Medical - Care Facilities
- CEO Martin J. Bonick
- Employees 19200